Estrogen Receptors in Resistance to Hormone Therapy-Reference-Cited by-同舟云学术

Estrogen Receptors in Resistance to Hormone Therapy

Published:2007 Issue: Volume: Page:130-143
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Herynk Matthew H.,Fuqua Suzanne A. W.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-0-387-74039-3_10.pdf

Reference164 articles.

1. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998; 3(1):49–61.

2. Di Leo A, Messa C, Cavallini A et al. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1(1):1–12.

3. Pujol P, Rey JM, Nirde P et al. Differential expression of estrogen receptor-alpha and-beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 1998; 58(23):5367–5373.

4. Feigelson HS, Ross RK, Yu MC et al. Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem Suppl 1996; 25:15–22.

5. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998; 90(11):814–823.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy;Tumors of female reproductive system;2022-12-02

2. Novel 11β-substituted estradiol conjugates: Transition from ERα agonizts to effective PROTAC degraders;The Journal of Steroid Biochemistry and Molecular Biology;2022-10

3. Novel psoralen derivatives as anti-breast cancer agents and their light-activated cytotoxicity against HER2 positive breast cancer cells;Scientific Reports;2022-08-05

4. Tetrahydro-β-carboline-naphthalimide hybrids: Synthesis and anti-proliferative evaluation on estrogen-dependent and triple-negative breast cancer cells;Journal of Molecular Structure;2022-08

5. Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer;Frontiers in Oncology;2021-04-22